Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $35.06 USD
Change Today +0.28 / 0.81%
Volume 14.0K
LDR On Other Exchanges
Symbol
Exchange
New York
Frankfurt
As of 1:44 PM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

landauer inc (LDR) Snapshot

Open
$34.61
Previous Close
$34.78
Day High
$35.34
Day Low
$34.07
52 Week High
05/28/14 - $48.80
52 Week Low
01/30/15 - $27.87
Market Cap
336.0M
Average Volume 10 Days
76.6K
EPS TTM
$1.98
Shares Outstanding
9.6M
EX-Date
03/17/15
P/E TM
17.8x
Dividend
$1.10
Dividend Yield
5.47%
Current Stock Chart for LANDAUER INC (LDR)

Related News

No related news articles were found.

landauer inc (LDR) Related Businessweek News

No Related Businessweek News Found

landauer inc (LDR) Details

Landauer, Inc., together with its subsidiaries, provides technical and analytical services, outsourced medical physics services, and radiology related medical products Worldwide. The company operates in three segments: Radiation Measurement, Medical Physics, and Medical Products. The Radiation Measurement segment provides analytical services to determine occupational and environmental radiation exposure; manufactures various radiation detection monitors; and distributes and collects monitors to and from customers, as well as analyzes and reports exposure findings. It also sells dosimetry detectors and reading equipment. This segment provides its services primarily to hospitals, medical and dental offices, universities, national laboratories, nuclear facilities, and other industries. The Medical Physics segment offers therapeutic and imaging physics services comprising clinical physics support, equipment commissioning, accreditation support, and imaging equipment testing to hospitals, radiation therapy centers, and imaging centers. The Medical Products segment provides medical consumable accessories that are used in radiology, radiation therapy, and image guided surgery procedures. It products include consumables used with MRI, CT, and mammography technologies; and passive reflective markers used during image guided surgery procedures. The company was founded in 1954 and is based in Glenwood, Illinois.

600 Employees
Last Reported Date: 02/3/15
Founded in 1954

landauer inc (LDR) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $59.8K
Chief Financial Officer
Total Annual Compensation: $252.9K
Vice President of Global Marketing and Presid...
Total Annual Compensation: $247.2K
President of Radiation Measurement
Total Annual Compensation: $350.0K
Compensation as of Fiscal Year 2014.

landauer inc (LDR) Key Developments

Landauer Inc. Seeks Acquisitions

Michael Leatherman, Chief Executive Officer of Landauer Inc. said that small, tuck-in, bolt-on and strategic acquisitions will help company to grow more quickly.

Landauer Inc. Declares Quarterly Dividend, Payable on April 3, 2015; Reports Consolidated Earnings Results for the First Quarter Ended December 31, 2014; Provides Earnings Guidance for the Fiscal Year 2015

Landauer Inc. announced that the Board of Directors declared a dividend of $0.275 per share, which is a reduction from the previous quarter's dividend of $0.55 per share. The dividend is payable on April 3, 2015 to shareholders of record on March 19, 2015. The company reported consolidated earnings results for the first quarter ended December 31, 2014. For the period, the company reported revenues were $37.5 million, a decrease 1.6%, compared with revenues of $38.1 million for the first fiscal quarter of 2014. The Radiation Measurement segment revenue decreased 6.0% to $26.5 million, due to a $0.8 million unfavorable foreign currency impact and a $0.7 million decrease in sales of military products. The Medical Physics segment increased 9.1% to $8.4 million, due to increased imaging and radiation therapy services. The Medical Products segment increased 18.2% to $2.6 million, due to higher domestic revenues and the full-quarter impact in fiscal 2015 of a modest acquisition in December 2013. Operating income for the first fiscal quarter of 2015 was $6.1 million, an increase of $0.7 million, or 13.0%, compared with operating income of $5.4 million for the first fiscal quarter of 2014. The increase in operating income was driven by a $0.9 million decrease in research and development expenses, offset by an increase in selling, general and administrative expenses of $0.3 million. Net income attributed to the company for the first fiscal quarter of 2015 was $4.4 million or $0.46 per basic and diluted share, an increase of $0.6 million, or 15.8%, compared with net income of $3.8 million or $0.40 per basic and diluted share in the first fiscal quarter of 2014. The increase in net income was the result of a decrease in operating expenses of $0.7 million and a decrease in income tax provision of $0.3 million, partially offset by a decrease in equity in income of joint ventures of $0.6 million. Excluding the costs associated with an acquisition, and non-cash stock based compensation expenses, adjusted net income was $4.7 million, compared to adjusted net income of $4.1 million in the comparable prior year period. The resulting adjusted diluted earnings per share for the first fiscal quarter ended December 31, 2014 was $0.50 per share, compared to $0.43 per share in the same period last year. The company reported Adjusted EBITDA of $10.3 million in the first fiscal quarter of 2015 compared with $10.6 million for the first fiscal quarter of 2014. Net operating cash flow generated during the first fiscal quarter of 2015 was $9.5 million against $9.939 million a year ago, representing a decrease from the prior year period of $0.5 million. Income before taxes was $6.135 million against $5.928 million a year ago. Capital expenditures were $1.384 million against $1.245 million a year ago. Adjusted free cash flow was $8.100 million against $8.805 million a year ago. For the fiscal 2015, the company currently anticipates aggregate revenues for the year to be in the range of $153 to $163 million. This range reflects the uncertainty of government funding during fiscal 2015 for military equipment sales opportunities as well as the outlook for foreign currencies. The business plan also anticipates: The effective tax rate for the full fiscal year is anticipated to be within a range of 28% to 32%. The company anticipates adjusted net income for fiscal 2015 in the range of $16 to $19 million and Adjusted EBITDA expected for fiscal 2015 in the range of $41 to $46 million.

Landauer Inc. to Report Q1, 2015 Results on Mar 09, 2015

Landauer Inc. announced that they will report Q1, 2015 results at 5:00 PM, Eastern Standard Time on Mar 09, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LDR:US $35.06 USD +0.28

LDR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alphatec Holdings Inc $1.41 USD +0.01
Globus Medical Inc $24.40 USD +0.33
NuVasive Inc $44.53 USD +0.55
Orthofix International NV $30.02 USD -0.20
View Industry Companies
 

Industry Analysis

LDR

Industry Average

Valuation LDR Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 2.1x
Price/Book 32.9x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LANDAUER INC, please visit www.landauerinc.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.